@article{article, title  = {{Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial}},

 url = {{http://eprints.whiterose.ac.uk/93786/ }},

 year = {{2015}},

 month = {{12}},

 author = {{Yardley DA and Brufsky A and Coleman RE and Conte PF and Cortes J and Glück S and Nabholtz J-MA and O’Shaughnessy J and Beck RM and Ko A and Renschler MF et al}},

 doi = {{10.1186/s13063-015-1101-7}},

 volume = {{16}},

 journal = {{Trials}},

 note = {{Accessed on 2025/10/10}}}